IMMX
Immix Biopharma Inc
9.70$
-5.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.4% | 99.3% | 95.8% | 94.8% | 90.5% | 88.0% | 84.4% | 78.8% | 82.6% | 96.6% | 96.3% | 97.8% | |
| 87.1% | 87.9% | 85.4% | 83.1% | 78.3% | 77.1% | 80.0% | 74.4% | 79.4% | 89.6% | 82.7% | 94.3% | |
| 87.1% | 87.9% | 85.4% | 83.1% | 78.3% | 77.1% | 80.0% | 74.4% | 79.4% | 95.8% | 94.5% | 97.1% | |
| 2.9% | 5.9% | 5.9% | 6.9% | 7.9% | 8.6% | – | – | – | – | – | – | |
| – | – | 0.0% | – | – | – | – | – | – | – | – | – | |
| 12.6% | 18.7% | 19.6% | 17.1% | 30.2% | 42.3% | 51.8% | 70.2% | 58.8% | 10.5% | 12.0% | 4.3% | |
| 12.6% | 18.7% | 16.5% | 13.5% | 26.1% | 37.9% | 46.8% | 64.0% | 54.0% | 9.6% | 11.0% | 3.9% | |
| – | – | 0.1% | 0.2% | 0.2% | 0.3% | 0.3% | 0.5% | 0.7% | 0.1% | 0.1% | 0.0% | |
| 7.0% | 7.2% | 10.2% | 8.1% | 13.1% | 23.5% | 28.9% | 42.3% | 35.1% | 5.2% | 4.9% | 2.2% | |
| 88.0% | 82.3% | 81.3% | 82.9% | 69.8% | 57.7% | 48.2% | 29.8% | 41.2% | 89.5% | 88.0% | 95.7% | |
| -215.0% | -268.1% | -170.8% | -218.7% | -279.3% | -326.9% | -400.0% | -551.3% | -467.0% | -99.6% | -119.6% | -52.7% | |
| 82.7% | 100.0% | 68.2% | 99.8% | 117.0% | 120.0% | 149.3% | 191.8% | 159.0% | 36.5% | 57.8% | 26.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.